William Blair & Company’s Arena Pharmaceuticals Inc ARNA Stock Holding History

William Blair & Company’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-80,664	Closed	-$7.5M	–	2037
2021 Q4	$7.5M	Buy	+80,664	New	+$5.31M	0.02%	401

William Blair & Company's ARNA Position: Q1 2022 in Review

William Blair & Company sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 80,664 shares — an estimated $7.5M sold.

William Blair & Company first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $7.5M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

William Blair & Company reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
William Blair & Company sold 80,664 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $7.5M.
William Blair & Company first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
William Blair & Company's Arena Pharmaceuticals Inc position peaked at $7.5M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on William Blair & Company's 13F filing for Q1 2022, filed 13 May 2022.